Also Known As:
Oncomine Myeloid DNA Panel
This targeted DNA test helps identify genetic mutations associated with myeloid cancers, including acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). It provides crucial information to help your doctor evaluate and manage related conditions.
Includes 1 Test Parameters
Test Preparation:
No Special Preparation. Informed Consent Required.
Reporting TAT:
24 Hours